Madrigal Pharmaceuticals
MDGL
#1712
Rank
S$16.16 B
Marketcap
S$700.97
Share price
-0.08%
Change (1 day)
78.93%
Change (1 year)

Earnings for Madrigal Pharmaceuticals (MDGL)

Earnings in 2026 (TTM): -S$0.37 Billion

According to Madrigal Pharmaceuticals 's latest financial reports the company's current earnings are S$1.13 Billion. In 2025 the company made an earning of -S$0.35 Billion, an increase over its 2024 earnings that were of -S$0.59 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Madrigal Pharmaceuticals from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.37 Billion5.71%
2025 -S$0.35 Billion-41.05%
2024 -S$0.59 Billion25.02%
2023 -S$0.47 Billion23.86%
2022 -S$0.38 Billion20.24%
2021 -S$0.32 Billion17.25%
2020 -S$0.27 Billion117.61%
2019 -S$0.13 Billion189.45%
2018 -S$42.37 Million3.85%
2017 -S$40.8 Million25.71%
2016 -S$32.46 Million-50.81%
2015 -S$65.98 Million-39.14%
2014 -S$0.11 Billion-4.12%
2013 -S$0.12 Billion
2011 -S$58.66 Million23.13%
2010 -S$47.65 Million-145.81%
2009 S$0.10 B-185.95%
2008 -S$0.13 Billion41.52%
2007 -S$85.5 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-S$0.3 Billion-18.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-S$23.45 Million-93.58%๐Ÿ‡บ๐Ÿ‡ธ USA